Ryogen is Awarded New Patent

Ryogen is Awarded New Patent Patented DNA Sequence Encodes a Protein Implicated in Diabetes, Metabolic Syndrome, Immune Dysfunctions and Other Diseases Suffern, N.Y. (PRWEB) November 13, 2009 -- Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7". U.S. patent No. 7,588,915, issued by the U.S. Patent and Trademark Office, claims isolated genomic polynucleotide fragments that encode human adipocyte enhancer binding protein 1 (AEBP1), complementary
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations